当前位置: 首页 > 期刊 > 《中国医学创新》 > 2016年第14期
编号:12858537
植入式医疗器件供电方式研究现状及展望(5)
http://www.100md.com 2016年5月15日 《中国医学创新》 2016年第14期
     [24] Greenborg J,Smith T H,Matheson W E.Risk/benefit analysis of the Betacel nuclear-powered pacemaker[J].Transactions of the American Nuclear Society,1973,17(6):100-101.

    [25]Parsonnet V,Driller J,Cook D,et al. Thirty-one years of clinical experience with “nuclear-powered” pacemakers[J].Pacing Clin Electrophysiol,2006,29(2):195-200.

    [26] Aludaat C,Gay A,Guetlin A,et al. Favorable evolution of a 43-year-old starr-edwards valve in the tricuspid position[J].

    J Heart Valve Dis,2012, 21(5):679-681.

    [27] Royle T J,Davies R E,Gannon M X.Totally implantable venous access devices-20 years’ experience of implantation in cystic fibrosis patients[J].Ann R Coll Surg Engl,2008,90(8):679-684.

    [28] Dubner S,Auricchio A,Steinberg J S,et a1.Ishne/ehra expert consensus on remote monitoring of cardiovascular implantable electronic devices (cieds)[J].Europace,2012,14(2):278-93.

    [29] Pantchenko O S,Seidman S J,Guag J W,et al.Electromagnetic compatibility of implantable neurostimulators to rfid emitters[J].Biomed Eng Online,2011,10(1):50.

    [30] Ivorra A.Remote electrical stimulation by means of implanted rectifiers[J].PLoS One,2011,6(8):e23 456.

    [31] Said S,Cooper C J,Alkhateeb H,et al.Incidence of new onset atrial fibrillation in patients with permanent pacemakers and the relation to the pacing mode[J].Med Sci Monit,2014,20(9): 268-273.

    (收稿日期:2016-01-15) (本文编辑:蔡元元), 百拇医药(何钟杰 陈露 漆双艳)
上一页1 2 3 4 5